drugset / Trial / NCT00240032
A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is designed to compare injection skin (injection site) reactions when an antihistamine (Zyrtec®) or placebo is taken prior to performing daily Copaxone® injections. Patients will be assigned (like a flip of a coin) to take either a placebo or an antihistamine (Zyrtec®) prior to performing their daily Copaxone® injections. The patient and physician will be unaware whether they are taking a placebo or antihistamine during the study.
Timeline
- Start
- 2004-10
- Primary completion
- 2006-06
- Completion
- 2006-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cetirizine | Other / unclassified | 10 mg | Oral |
| Comparator | Glatiramer Acetate | Small molecule | 20 mg | — |